ViaDerma, Inc. Stock

VDRM

US92555K1016

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 13:45:59 2026-06-03 EDT			5-day change	1st Jan Change
0.000300 ^USD	-25.00%		-25.00%	+50.00%

25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	CI
24-08-13	ViaDerma, Inc. Announces Commencement of the Registration Process in Kenya, Namibia, and Tanzania for Strategic Expansion into East and Southern Africa	CI

ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Companyâ€™s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Companyâ€™s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Companyâ€™s subsidiary is ViaDerma, II Inc.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-07-31	US$0.000100	+9,900.00%	10,000

Real-time OTC Markets

More quotes

Stock Market
Stocks
VDRM Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	6.31M 5.48M 5.1M 4.68M 8.85M 602M 8.98M 60.14M 23.6M 300M 23.68M 23.16M 1B	P/E 2015	10.7x	P/E 2016	-3.3x
Enterprise Value	6.6M 5.74M 5.34M 4.9M 9.26M 630M 9.41M 62.97M 24.71M 314M 24.8M 24.25M 1.05B	EV / Sales 2015	1.5x	EV / Sales 2016	3.63x
Free-Float	99%	Yield 2015 *	-	Yield 2016	-

25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	CI
24-08-13	ViaDerma, Inc. Announces Commencement of the Registration Process in Kenya, Namibia, and Tanzania for Strategic Expansion into East and Southern Africa	CI
24-08-13	ViaDerma, Inc. Announces Shipment of 500,000 Units of its Product to Nigeria	CI
24-08-01	ViaDerma, Inc. Finalizes Distribution Agreements in Dubai	CI
23-03-16	ViaDerma, Inc. Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product	CI
23-03-08	ViaDerma Announces Intent to Launch New Minoxidil Hair Regrowth Product	CI
22-09-15	ViaDerma, Inc. Successfully Completes Quality Control Testing of Its New Vitastem Products	CI
21-10-04	ViaDerma, Inc. Set to Launch Two New and Improved Versions of Its Flagship Product, Vitastem and Vitastem Ultra	CI
21-06-24	ViaDerma, Inc. Provides Updates on Current Business Activities	CI
21-06-02	ViaDerma, Inc. Announces Expansion of Its Current Licensing Agreement	CI
21-05-13	ViaDerma, Inc. Nearing Initial Order from Large Hospital Network	CI
21-04-08	ViaDerma, Inc. Provides Revenue Guidance for the First Quarter of 2021	CI
21-01-21	ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States	CI

25-07-16	ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes	AQ
25-06-04	ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance	AQ
25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	AQ
24-12-10	ViaDerma Announces Significant 2024 Achievements and International Expansion	AQ
24-10-03	ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth	AQ

1 day	-25.00%
1 week	-25.00%
Current month	+200.00%
3 months	-25.00%
6 months	-25.00%
Current year	+50.00%

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0.01
3 years	0		0.02
5 years	0		0.03
10 years	0		0.08

ViaDerma, Inc. Stock

Stocks

VDRM

US92555K1016

Biotechnology & Medical Research

Valuation: ViaDerma, Inc.

Chart: ViaDerma, Inc.

Latest news : ViaDerma, Inc.

Press Releases: ViaDerma, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: ViaDerma, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VIADERMA, INC.	-25.00%	-25.00%	-82.35%	-97.22%	123K
LONZA GROUP AG	-1.40%	+2.59%	-1.71%	+11.28%	48.53B
REVOLUTION MEDICINES, INC.	-2.41%	-0.90%	+411.96%	+495.33%	39.87B
IQVIA HOLDINGS INC.	-1.16%	+12.96%	+28.81%	+7.25%	38.68B
BEONE MEDICINES AG	-1.88%	-3.03%	+5.69%	+53.00%	35.13B
CELLTRION, INC.	-1.74%	+5.12%	+14.44%	+41.77%	29.79B
MEDPACE HOLDINGS, INC.	-0.21%	-4.04%	+36.40%	+125.75%	16.11B
ASCENDIS PHARMA A/S	-2.85%	-3.92%	-	-	16.08B
EUROFINS SCIENTIFIC SE	-0.64%	+2.65%	+3.40%	+13.11%	13.61B
ICON PUBLIC LIMITED COMPANY	-1.19%	-1.32%	-1.73%	-34.37%	12.62B
Average	-3.85%	+0.95%	+46.10%	+68.43%	25.04B
Weighted average by Cap.	-1.60%	+2.03%	+79.78%	+108.61%

	2015	2016
Net sales	192K 167K 155K 142K 269K 18.31M 273K 1.83M 718K 9.11M 720K 704K 30.56M	252K 219K 204K 187K 353K 24.05M 359K 2.4M 943K 11.98M 946K 926K 40.15M
Net income	27.12K 23.58K 21.94K 20.15K 38.05K 2.59M 38.64K 259K 102K 1.29M 102K 99.62K 4.32M	-122K -106K -98.56K -90.49K -171K -11.63M -174K -1.16M -456K -5.79M -457K -447K -19.41M
Net Debt	288K 251K 233K 214K 404K 27.51M 411K 2.75M 1.08M 13.7M 1.08M 1.06M 45.93M	297K 258K 240K 220K 416K 28.33M 423K 2.83M 1.11M 14.1M 1.11M 1.09M 47.29M